Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralinand apomorphine-induced disruptions of prepulse inhibition: Involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT 2A, or 5-HT7 Receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 1, 2010, Pages 218-227

  Gogos, Andrea ^a,b   Kwek, Perrin ^a   Chavez, Carolina ^a,b   Van Den Buuse, Maarten ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ESTRADIOL; ESTROGEN; HALOPERIDOL; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; SEROTONIN 7 RECEPTOR; SILASTIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ESTRADIOL BLOOD LEVEL; FEMALE; NONHUMAN; OVARIECTOMY; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; UTERUS WEIGHT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; APOMORPHINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; FEMALE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; STARTLE REACTION;

EID: 77949735855     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.162123     Document Type: Article

References (40)

1. Albert DJ, Jonik RH, Gorzalka BB, Newlove T, Webb B, and Walsh ML (1991) Serum estradiol concentration required to maintain body weight, attractivity, proceptivity, and receptivity in the ovariectomized female rat. Physiol Behav 49:225-231.
2. Alex KD and Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320.
3. Azmitia EC and Whitaker-Azmitia PM (1995) Anatomy, cell biology, and plasticity of the serotonergic system. Neuropsychopharmacological implications for the actions of psychotropic drugs, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 443-449, Raven Press, New York.
4. Bantick RA, Deakin JF, and Grasby PM (2001) The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15:37-46.
5. Barnes NM and Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
6. Bethea CL, Pecins-Thompson M, Schutzer WE, Gundlah C, and Lu ZN (1998) Ovarian steroids and serotonin neural function. Mol Neurobiol 18:87-123.
7. Braff DL, Freedman R, Schork NJ, and Gottesman II (2007) Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 33:21-32.
8. Braff DL, Geyer MA, and Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234-258.
9. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, and Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381-389.
10. Cyr M, Landry M, and Di Paolo T (2000) Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 23:69-78.
11. Dean B (2003) The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice. J Neurochem 85:1-13.
12. Doherty MD and Pickel VM (2001) Targeting of serotonin 1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain. J Comp Neurol 433:390-400.
13. Geyer MA and Markou A (1995) Animal models of psychiatric disorders, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 787-798, Raven Press, New York.
14. Geyer MA, Krebs-Thomson K, Braff DL, and Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117-154.
15. Gogos A and van den Buuse M (2003) Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. Behav Neurosci 117:1407-1415.
16. Gogos A and Van den Buuse M (2004) Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J Pharmacol Exp Ther 309:267-274.
17. 1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 31:885-889.
18. Gogos A, van den Buuse M, and Rossell S (2009) Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI. Int J Neuropsychopharmacol 12:1249-1259.
19. Häfner H, Riecher-Rössler A, An Der Heiden W, Maurer K, Fätkenheuer B, and Löffler W (1993) Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 23:925-940.
20. Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122:593-624.
21. 3H]-8-OH- DPAT. Pharmacol Biochem Behav 68:221-227.
22. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A, Schwartz MP, Gonzenbach S, Rotrosen JP, and Duncan EJ (2004) Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41:401-406.
23. Kebabian JW and Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93-96.
24. Koch M (1998) Sensorimotor gating changes across the estrous cycle in female rats. Physiol Behav 64:625-628.
25. Kulkarni J, Riedel A, de Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J, and Burger H (2001) Estrogen - a potential treatment for schizophrenia. Schizophr Res 48: 137-144.
26. 1A) receptor activation. Life Sci 48:1627-1632.
27. Newman-Tancredi A, Assié MB, Leduc N, Ormière AM, Danty N, and Cosi C (2005) Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. Int J Neuropsychopharmacol 8:341-356.
28. Protais P, Lesourd M, and Comoy E (1998) Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Eur J Pharmacol 352:179-187.
29. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, and Schmidt R (1994) Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20:203-214.
30. Seeman MV and Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16:185-194.
31. Shughrue PJ, Lane MV, and Merchenthaler I (1997) Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388:507-525.
32. Sipes TA and Geyer MA (1995) 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology 117:41-48.
33. 2A receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 54:15-20.
34. Swerdlow NR, Auerbach P, Monroe SM, Hartston H, Geyer MA, and Braff DL (1993) Men are more inhibited than women by weak prepulses. Biol Psychiatry 34:253-260.
35. Swerdlow NR, Hartman PL, and Auerbach PP (1997) Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 41:452-460.
36. Swerdlow NR, Keith VA, Braff DL, and Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536.
37. van den Buuse M (2003) Deficient prepulse inhibition of acoustic startle in Hooded-Wistar rats compared with Sprague-Dawley rats. Clin Exp Pharmacol Physiol 30:254-261.
38. van den Buuse M and Gogos A (2007) Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition. J Pharmacol Exp Ther 320:1224-1236.
39. Van Hartesveldt C and Joyce JN (1986) Effects of estrogen on the basal ganglia. Neurosci Biobehav Rev 10:1-14.
40. Wan FJ, Taaid N, and Swerdlow NR (1996) Do D1/D2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology 14:265-274.